Titre : | Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems : the impact of substance abuse treatment |
Titre traduit : | (Observance de la thérapie antirétrovirale intensive chez les porteurs du VIH ayant des problèmes d'alcool et de drogues : l'impact du traitement contre l'abus de drogues) |
Auteurs : | A. PALEPU ; N. J. HORTON ; TIBBETTS N. ; S. MELI ; J. H. SAMET |
Type de document : | Périodique |
Année de publication : | 2004 |
Format : | 361-368 / tabl. |
Note générale : |
Addiction, 2004, 99, (3), 361-368 |
Langues: | Anglais |
Discipline : | TRA (Traitement et prise en charge / Treatment and care) |
Mots-clés : |
Thésaurus mots-clés VIH ; ANTIRETROVIRAUX ; OBSERVANCE DU TRAITEMENT ; ALCOOL ; PSYCHOTROPES ; DEPENDANCE ; TRAITEMENT |
Résumé : |
ENGLISH : Aim : We examined the association of substance abuse treatment with uptake, adherence and virological response to highly active antiretroviral therapy (HAART) among HIV-infected people with a history of alcohol problems. Design : Prospective cohort study Methods : A standardized questionnaire was administered to 349 HIV-infected participants with a history of alcohol problems regarding demographics, substance use, use of substance abuse treatment and uptake of and adherence to HAART. These subjects were followed every 6 months for up to seven occasions. We defined substance abuse treatment services as any of the following in the past 6 months : 12 weeks in a half-way house or residential facility ; 12 visits to a substance abuse counselor or mental health professional ; or participation in any methadone maintenance program. Our outcome variables were uptake of antiretroviral therapy 30-day self-reported adherence and HIV viral load suppression. Findings At baseline, 59% (205/349) of subjects were receiving HAART. Engagement in substance abuse treatment was independently associated with receiving antiretroviral therapy (adjusted OR ; 95% CI : 1.70 ; 1.03-2.83). Substance abuse treatment was not associated with 30-day adherence or HIV viral load suppression. More depressive symptoms (0.48 ; 0.32-0.78) and use of drugs or alcohol in the previous 30 days (0.17 ; 0.11-0.28) were associated with worse 30-day adherence. HIV viral load suppression was positively associated with higher doses of antiretroviral medication (1.29 ; 1.15-1.45) and older age (1.04 ; 1.00-1.07) and negatively associated with use of drugs or alcohol in the previous 30 days (0.51 ; 0.33-0.78). Conclusion : Substance abuse treatment was associated with receipt of HAART ; however, it was not associated with adherence or HIV viral load suppression. Substance abuse treatment programs may provide an opportunity for HIV-infected people with alcohol or drug problems to openly address issues of HIV care including enhancing adherence to HAART. (Review' s abstract) |
Note de contenu : | tabl. |
Domaine : | Drogues illicites / Illicit drugs |
Refs biblio. : | 50 |
Affiliation : |
Ctr. Health. Evaluation Outcome Sc., St Paul's Hosp., Dpt. Med., Univ. British Columbia, Vancouver, British Columbia. ; anitahivnet.ubc.ca Canada. Canada. |
Numéro Toxibase : | 207315 |
Centre Emetteur : | 02 Coordonnateur |
Exemplaires
Disponibilité |
---|
aucun exemplaire |
